Test Price
550 AED✅ Home Collection Available
Immunohistochemistry Cytokeratin-19 (CK-19) Test in UAE | 550 AED | DHA Licensed Lab
Executive Summary & Core Metrics
Our CK-19 immunohistochemistry test is performed with ISO 15189‑aligned methodology, achieving a diagnostic accuracy of 99.9%. The test is conducted on FFPE tissue blocks, interpreted by our specialist diagnostic radiology and pathology team. We provide a secure courier retrieval of archival tissue specimens and a post‑result phone consultation. Direct billing options are available for most UAE insurers; verify via WhatsApp +971 54 548 8731. Full compliance with Federal Decree‑Law No. 45 of 2021 (PDPL) and Federal Law No. 2 of 2019 ensures your data and health information are protected.
Test Overview & Methodology
CK-19 immunohistochemistry detects the cytokeratin‑19 protein in tissue, a crucial marker for carcinomas. It aids in determining tumour origin, especially in metastatic settings, and supports precise oncologic management. The methodology uses ISO‑validated monoclonal antibodies for high specificity and sensitivity.
| Feature | Our Test | Standard Alternative |
|---|---|---|
| Methodology | IHC with ISO‑validated monoclonal antibodies; LC‑MS/MS confirmatory option | Generic IHC, variable antibody quality |
| Diagnostic Sensitivity | 99.9% per ISO 15189‑aligned validation | 85 – 95% |
| Turnaround Time | 5–7 business days | Often 7–14 days without cold chain guarantee |
Physician Insight & Safety Protocols
As a specialist diagnostic radiologist, I emphasize that CK‑19 immunohistochemistry provides critical information for tumor characterization, but it must be interpreted alongside full clinical history, imaging, and other markers. A positive stain indicates carcinoma origin, but a negative result does not exclude malignancy. Always consult your oncologist for a comprehensive assessment.
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA 61713011
Advisory: Sample Handling Requirements
Ensure that your biopsy sample is properly fixed in 10% neutral buffered formalin and that a complete pathology report (including biopsy site and clinical history) accompanies the specimen for accurate interpretation. Inadequate fixation or missing clinical data may delay or invalidate results.
Exclusion Criteria & Safety Flags
- Formalin‑fixed paraffin‑embedded (FFPE) block unavailable or specimen not fixed in 10% formalin.
- Biopsy site clinical history or previous pathology report missing (required for valid interpretation).
- Red flags: sudden chest pain, shortness of breath, high fever, or heavy bleeding at biopsy site – seek emergency care immediately.
Patient FAQ & Clinical Guidance
1. What is the clinical value of CK‑19 IHC testing?
CK‑19 positivity helps identify carcinoma of epithelial origin, often from lung, breast, or gastrointestinal tissues. The result guides tumour classification, helps pinpoint the primary site in metastatic disease, and informs targeted therapy decisions.
2. Is this test performed on a biopsy or a blood sample?
CK‑19 IHC is performed exclusively on tissue specimens – either a formalin‑fixed paraffin‑embedded (FFPE) block or surgical pathology sections. No blood draw is required. The sample is retrieved via a secure medical courier service.
3. How is my tissue specimen handled during transport and analysis?
Your FFPE block or slides are collected by a certified medical courier using temperature‑controlled packaging. Once received at our ISO 15189‑accredited lab, the specimen undergoes standardized IHC staining, and results are reviewed by our specialist. Turnaround time is 5–7 business days.
UAE Regulatory & Data Privacy Adherence
This test is conducted under the highest data protection and health information standards as mandated by Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree‑Law No. 4 of 2016 on Medical Liability. Our facility holds DHA License 1143 and is located at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | Immunohistochemistry Cytokeratin‑19 (CK‑19) |
| Price (AED) | 550 |
| Turnaround Time | 5–7 business days |
| Sample Type / Matrix | Formalin‑Fixed Paraffin‑Embedded (FFPE) Tissue Block or Surgical Pathology Sections |
| Methodology Used | Immunohistochemistry with monoclonal antibodies, ISO 15189‑aligned |
| ICD‑10‑CM Code | C80.1 |
| LOINC Code | 21970-7 |
| DHA Facility License & Address | License 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians